PL356832A1 - Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate - Google Patents

Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate

Info

Publication number
PL356832A1
PL356832A1 PL01356832A PL35683201A PL356832A1 PL 356832 A1 PL356832 A1 PL 356832A1 PL 01356832 A PL01356832 A PL 01356832A PL 35683201 A PL35683201 A PL 35683201A PL 356832 A1 PL356832 A1 PL 356832A1
Authority
PL
Poland
Prior art keywords
cyclohexanecarboxylate
cyclopentyloxy
monohydrate
methoxyphenyl
cis
Prior art date
Application number
PL01356832A
Other languages
English (en)
Polish (pl)
Inventor
Kevin Scott Webb
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of PL356832A1 publication Critical patent/PL356832A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL01356832A 2000-01-26 2001-01-18 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate PL356832A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17812900P 2000-01-26 2000-01-26
PCT/US2001/001487 WO2001055094A1 (en) 2000-01-26 2001-01-18 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate

Publications (1)

Publication Number Publication Date
PL356832A1 true PL356832A1 (en) 2004-07-12

Family

ID=22651319

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01356832A PL356832A1 (en) 2000-01-26 2001-01-18 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate

Country Status (36)

Country Link
US (1) US6699903B2 (es)
EP (1) EP1250313B1 (es)
JP (1) JP2003520842A (es)
KR (1) KR20020073183A (es)
CN (1) CN1157371C (es)
AP (1) AP1432A (es)
AR (1) AR027273A1 (es)
AT (1) ATE344235T1 (es)
AU (1) AU3282201A (es)
BG (1) BG106959A (es)
BR (1) BR0107709A (es)
CA (1) CA2397758A1 (es)
CO (1) CO5300517A1 (es)
CY (1) CY1108515T1 (es)
CZ (1) CZ20022590A3 (es)
DE (1) DE60124221T2 (es)
DK (1) DK1250313T3 (es)
DZ (1) DZ3285A1 (es)
EA (1) EA200200791A1 (es)
EG (1) EG24065A (es)
ES (1) ES2273804T3 (es)
HK (1) HK1051030A1 (es)
HU (1) HUP0204150A3 (es)
IL (1) IL150400A0 (es)
MA (1) MA25652A1 (es)
MX (1) MXPA02007300A (es)
MY (1) MY122802A (es)
NO (1) NO20023378D0 (es)
NZ (1) NZ519799A (es)
OA (1) OA12159A (es)
PE (1) PE20011040A1 (es)
PL (1) PL356832A1 (es)
PT (1) PT1250313E (es)
SK (1) SK10942002A3 (es)
WO (1) WO2001055094A1 (es)
ZA (1) ZA200205925B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011802D0 (en) * 2000-05-16 2000-07-05 Smithkline Beecham Method for enhancing cognitive function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK279958B6 (sk) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Zlúčeniny s protialergickým a protizápalovým účink
UA67753C2 (uk) * 1997-10-10 2004-07-15 Смітклайн Бічам Корпорейшн Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот

Also Published As

Publication number Publication date
HUP0204150A2 (hu) 2003-04-28
ZA200205925B (en) 2003-11-21
NO20023378L (no) 2002-07-12
ES2273804T3 (es) 2007-05-16
MY122802A (en) 2006-05-31
CZ20022590A3 (cs) 2003-01-15
PE20011040A1 (es) 2001-10-31
AP1432A (en) 2005-06-20
EG24065A (en) 2008-05-08
DK1250313T3 (da) 2007-02-12
MA25652A1 (fr) 2002-12-31
PT1250313E (pt) 2007-01-31
SK10942002A3 (sk) 2002-11-06
HUP0204150A3 (en) 2003-05-28
AR027273A1 (es) 2003-03-19
BR0107709A (pt) 2002-11-19
DZ3285A1 (fr) 2001-08-02
CY1108515T1 (el) 2014-04-09
CN1395556A (zh) 2003-02-05
AP2002002566A0 (en) 2002-06-30
ATE344235T1 (de) 2006-11-15
CN1157371C (zh) 2004-07-14
EP1250313A4 (en) 2005-09-21
US20030032670A1 (en) 2003-02-13
EP1250313A1 (en) 2002-10-23
IL150400A0 (en) 2002-12-01
EA200200791A1 (ru) 2002-12-26
JP2003520842A (ja) 2003-07-08
DE60124221D1 (de) 2006-12-14
EP1250313B1 (en) 2006-11-02
CA2397758A1 (en) 2001-08-02
WO2001055094A1 (en) 2001-08-02
NO20023378D0 (no) 2002-07-12
HK1051030A1 (zh) 2003-07-18
KR20020073183A (ko) 2002-09-19
NZ519799A (en) 2004-04-30
BG106959A (en) 2003-05-30
AU3282201A (en) 2001-08-07
OA12159A (en) 2006-05-08
US6699903B2 (en) 2004-03-02
CO5300517A1 (es) 2003-07-31
DE60124221T2 (de) 2007-09-13
MXPA02007300A (es) 2002-11-29

Similar Documents

Publication Publication Date Title
AU2001227839A1 (en) Shower head
AU2001227815A1 (en) Chemically specific imaging of tissue
AU2001252135A1 (en) Therapeutic agents
HUP0302478A3 (en) Pharmaceutical solutions of modafinil compounds
AU2002219900A1 (en) Minimal identification of features
GB0105893D0 (en) Pharmaceutically active compounds
GB0107751D0 (en) Pharmaceutically active compounds
GB0106631D0 (en) Pharmaceutically active compounds
IL150400A0 (en) Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate
AU2001273903A1 (en) Therapeutic agents
SI1250313T1 (sl) Monohidrat cis-litij-ciano-4(3-(ciklopentiloksi)-4-metoksifenil) cikloheksankarboksilata
AU2002353803A1 (en) Direct resolution of racemic threo-methylphenidate hydrochloride
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AUPQ962800A0 (en) Surgical head camera
EP1237851A4 (en) SALES OF I CIS / I-4-CYANO-4-3- (CYCLOPENTYLOXY) -4-METHOXYPHENYL] CYCLHEXAN-1-CARBONIC ACID
AU2002246290A1 (en) Superstability of thin-walled structures
AU2002240837A1 (en) Identification of lead structures
AU2002237189A1 (en) New use of phencynonate hydrochloride
AU2002238356A1 (en) New use of phencynonate hydrochloride
GB0107359D0 (en) Hydroxamic and carboxylic acid derivatives
GB0107362D0 (en) Hydroxamic and carboxylic acid derivatives
AU2002250948A1 (en) Shower head
AU2002101016A4 (en) Head massaging device
AUPQ685200A0 (en) Head start
AUPR246201A0 (en) Cresolsulfonic acids

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed